3,5-Dimethoxybibenzyl
3,5-Dimethoxybibenzyl (compound 5) is a dihydrostilbene-derived marine Antibacterial Agent. 3,5-Dimethoxybibenzyl exhibits antifouling activity against marine microfouling organisms, macrofouling organisms, marine microalgae and specific marine bacteria. 3,5-Dimethoxybibenzyl can be used in studies of marine biofouling and antibacterial agents.
For research use only. We do not sell to patients.
- CAS No.: 78916-50-4
- Formula: C16H18O2
- Molecular Weight:242.32
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| RAW264.7 | IC50 |
50 μM
Compound: 7
|
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of NO release
Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of NO release
|
[PMID: 37852423] |
In Vitro
3,5-Dimethoxybibenzyl (compound 5) (0.1-4 mM; 3 days) exhibits weak inhibitory activity on root elongation of Lactuca sativa seedlings, with 77.9% root growth remaining even at the concentration of 4 mM[1].
3,5-Dimethoxybibenzyl (0.1-10 μg/mL; 5 days) inhibits the attachment of Balanus improvisus nauplii, with an IC50 of 1.0 μg/mL, and shows low toxicity (7.7%) at 5 μg/mL[1].
3,5-Dimethoxybibenzyl (0.001-20 μg/mL; 5 days) inhibits metamorphosis of Ciona savignyi ascidian larvae via a toxic mode of action, with an IC50 of 3 μg/mL and an IC99 of 21.1 μg/mL[1].
3,5-Dimethoxybibenzyl (maximum concentration 10 μg/mL; 5 days) exhibits MIC values of 0.1, 0.1, 10, and 10 μg/mL against the attachment of H. coffeaeformis, P. roscoffensis, C. closterium, and P. purpureum, respectively. Its MIC values for inhibiting the growth of the aforementioned microalgae are 0.01, 0.01, 1, and 10 μg/mL, respectively.
3,5-Dimethoxybibenzyl (up to 10 μg/mL; 48 h) potently inhibits the growth of Halomonas aquamarina and Shewanella putrefaciens, with an MIC of 0.01 μg/mL for both, but shows no activity against the other 8 tested marine fouling bacterial strains at concentrations up to 10 μg/mL[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
3,5-Dimethoxybibenzyl (3-21.1 μg/mL; static exposure in seawater; 5 days) inhibits Ciona savignyi larval metamorphosis with an IC50 of 3 μg/mL and an IC99 of 21.1 μg/mL, acting via a toxic mode of action[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 78916-50-4
-
Molecular Weight 242.32
-
Formula C16H18O2
-
SMILES
O(C=1C=C(OC)C=C(C1)CCC=2C=CC=CC2)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)